|
LRRC40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.941200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.335400E-01 |
| Normal-vs-Stage2 |
4.347600E-01 |
| Normal-vs-Stage3 |
3.438400E-01 |
| Normal-vs-Stage4 |
4.553700E-02 |
| Stage1-vs-Stage2 |
7.287200E-01 |
| Stage1-vs-Stage3 |
9.460300E-02 |
| Stage1-vs-Stage4 |
5.595600E-03 |
| Stage2-vs-Stage3 |
2.146000E-01 |
| Stage2-vs-Stage4 |
8.638000E-02 |
| Stage3-vs-Stage4 |
4.994600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.949000E-01 |
| Normal-vs-AfricanAmerican |
4.980700E-03 |
| Normal-vs-Asian |
7.432200E-01 |
| Caucasian-vs-AfricanAmerican |
1.478190E-03 |
| Caucasian-vs-Asian |
9.353600E-01 |
| AfricanAmerican-vs-Asian |
1.477250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.978800E-01 |
| Normal-vs-Female |
5.793800E-01 |
| Male-vs-Female |
3.633200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.228400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.971600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.286800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.160600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.649850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.444400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.137000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.445600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.045200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.114600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.104360E-01 |
| Normal-vs-Grade 2 |
6.095800E-02 |
| Normal-vs-Grade 3 |
3.164400E-01 |
| Normal-vs-Grade 4 |
3.99240000004131E-06 |
| Grade 1-vs-Grade 2 |
4.743600E-01 |
| Grade 1-vs-Grade 3 |
3.550200E-02 |
| Grade 1-vs-Grade 4 |
6.4163000000006E-05 |
| Grade 2-vs-Grade 3 |
6.985000E-03 |
| Grade 2-vs-Grade 4 |
3.66100000315228E-08 |
| Grade 3-vs-Grade 4 |
3.242300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.18140000000689E-05 |
| Normal-vs-ccB subtype |
2.397300E-03 |
| ccA subtype-vs-ccB subtype |
4.9315995731547E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.738000E-01 |
| Normal-vs-N1 |
1.639000E-01 |
| N0-vs-N1 |
2.268200E-01 |
|
|
